Lamictal (lamotrigine) works primarily by blocking voltage-gated sodium channels in the brain, which calms overactive neurons and reduces the excessive release of excitatory brain chemicals. It’s FDA-approved for two main conditions: epilepsy (in patients aged 2 and older) and maintenance treatment of bipolar I disorder in adults. How it helps each condition involves overlapping but distinct pathways.
How It Calms Overactive Brain Cells
Your brain cells communicate by firing electrical signals. To fire, a neuron opens tiny sodium channels in its membrane, letting sodium ions rush in and triggering the signal. Lamotrigine binds to these sodium channels when they’re in a temporarily inactive state, slowing their recovery back to a ready-to-fire position. The net effect: neurons can still fire at normal rates, but rapid, repetitive firing (the kind that drives seizures) gets suppressed.
This selectivity is key. Because lamotrigine binds slowly to channels that are already in their inactive state, it preferentially targets neurons that are firing too fast while leaving normal brain signaling mostly untouched. Phenytoin, another seizure medication, works through a similar slow-binding mechanism, which is why both drugs can control seizures without heavily sedating people.
By stabilizing those sodium channels, lamotrigine also reduces the release of glutamate, the brain’s main excitatory chemical. Too much glutamate can overstimulate surrounding neurons and contribute to both seizure activity and the neural circuit dysfunction seen in mood disorders.
Why It Works for Epilepsy
Lamotrigine is approved as an add-on treatment for partial-onset seizures, primary generalized tonic-clonic seizures, and the generalized seizures of Lennox-Gastaut syndrome in patients aged 2 and older. For adults 16 and older with partial-onset seizures, it can also be used as a standalone treatment.
During a seizure, large groups of neurons fire in synchronized, high-frequency bursts. Lamotrigine’s ability to block sodium channels during rapid firing directly interrupts this pattern. It may also inhibit certain high-voltage calcium channels, adding another layer of control over excessive neurotransmitter release. Together, these effects raise the threshold for a seizure to start and make it harder for abnormal electrical activity to spread across the brain.
Why It Works for Bipolar Disorder
Lamotrigine stands apart from other mood stabilizers like lithium and valproate because its strongest benefit is preventing depressive episodes rather than manic ones. It’s approved specifically for maintenance treatment of bipolar I disorder, meaning it’s used long-term to delay the return of mood episodes after an acute episode has been treated.
The reasons it helps with bipolar depression go beyond simple sodium channel blockade. Research shows lamotrigine has a positive effect on the corticolimbic network, a set of brain circuits connecting emotional processing areas with higher-level thinking regions. Dysfunction in these circuits is a hallmark of bipolar depression, and lamotrigine appears to normalize their activity. It also interacts with the brain’s noradrenaline system and influences serotonin signaling pathways, both of which play roles in mood regulation.
There’s also evidence lamotrigine has neuroprotective properties. It increases levels of a protein called brain-derived neurotrophic factor (BDNF), which supports the health and growth of brain cells. It also boosts certain anti-cell-death signals. These effects may help protect neurons from the cumulative damage that repeated mood episodes can cause over time.
How Your Body Processes It
Lamotrigine has a half-life of about 29 hours, meaning it takes roughly that long for your body to clear half a dose. Your liver breaks it down primarily through a process called glucuronidation, which attaches a sugar molecule to the drug so your kidneys can excrete it. This metabolic pathway is important because other medications can speed it up or slow it down dramatically, changing how much lamotrigine stays in your bloodstream.
The most clinically significant interaction is with valproate (Depakote). Valproate slows lamotrigine’s metabolism so much that when the two are taken together, the lamotrigine dose typically needs to be cut by about 50% to avoid dangerously high levels. Going the other direction, if you stop valproate while still taking lamotrigine, your lamotrigine dose generally needs to be doubled to maintain stable blood levels.
Estrogen-containing birth control pills have the opposite effect. They speed up lamotrigine’s clearance so significantly that blood levels drop by more than 50% in women taking oral contraceptives compared to those who aren’t. This can reduce seizure control or mood stability without any change in your lamotrigine dose. If you start or stop hormonal birth control, your prescriber will likely need to adjust your lamotrigine dose accordingly.
Why Dosing Starts So Low
If you’ve been prescribed lamotrigine, you probably noticed it starts at a very low dose and increases slowly over weeks. The standard schedule for most adults begins at just 25 mg per day for the first two weeks, increases to 50 mg per day for weeks three and four, then goes up by 50 mg every one to two weeks until reaching a maintenance dose. This gradual approach isn’t about building up effectiveness slowly; it’s about minimizing the risk of a serious skin reaction.
A systematic review of over 18,600 patients in randomized controlled trials found that about 8.3% developed some kind of skin reaction while starting lamotrigine. Most of these rashes are mild and resolve on their own. The severe form, Stevens-Johnson syndrome or toxic epidermal necrolysis, occurred in about 0.04% of patients, roughly 1 in 2,500. The risk was slightly higher in people taking lamotrigine for seizures (0.07%) than for bipolar disorder (0.02%). Ramping the dose up too quickly is one of the strongest risk factors for these serious reactions, which is why the slow titration schedule exists and why skipping ahead isn’t recommended.
How It Differs From Other Mood Stabilizers
Lithium and valproate are generally more effective at preventing manic episodes, while lamotrigine’s strength lies on the depressive side of bipolar disorder. Research confirms that lamotrigine doesn’t appear to modulate the same biological targets that lithium and valproate act on, which likely explains this difference in clinical profile. For people whose bipolar disorder is dominated by depressive episodes rather than mania, lamotrigine is often a better fit. It’s also weight-neutral for most people and causes less cognitive dulling than some alternatives, which contributes to its tolerability over the years of treatment bipolar disorder typically requires.